Acute and persistent responses after H5N1 vaccination in humans.
CP: Immunology
CP: Microbiology
adjuvant
antigen-agnostic memory
baseline immune state
immune response dynamics
single cell analysis
systems immunology
trained immunity
vaccine
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
16
01
2024
revised:
14
04
2024
accepted:
16
08
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
aheadofprint
Résumé
To gain insight into how an adjuvant impacts vaccination responses, we use systems immunology to study human H5N1 influenza vaccination with or without the adjuvant AS03, longitudinally assessing 14 time points including multiple time points within the first day after prime and boost. We develop an unsupervised computational framework to discover high-dimensional response patterns, which uncover adjuvant- and immunogenicity-associated early response dynamics, including some that differ post prime versus boost. With or without adjuvant, some vaccine-induced transcriptional patterns persist to at least 100 days after initial vaccination. Single-cell profiling of surface proteins, transcriptomes, and chromatin accessibility implicates transcription factors in the erythroblast-transformation-specific (ETS) family as shaping these long-lasting signatures, primarily in classical monocytes but also in CD8
Identifiants
pubmed: 39235945
pii: S2211-1247(24)01057-X
doi: 10.1016/j.celrep.2024.114706
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114706Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests R.G.v.d.M. is a former employee of and holds shares in the GSK group of companies. B.S. is a former SomaLogic, Inc. (Boulder, CO, USA), employee and a company shareholder. J.S.T. serves on the scientific advisory boards of CytoReason, Immunoscape, and the Human Immunome Project.